Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

This study aimed to identify predictive factors associated with prognostic benefits of gefitinib. A total of 221 Japanese patients who received gefitinib (250 mg day(−1)) were examined retrospectively and potential predictive factors analysed. Overall response rate (ORR) was 24.4% and median surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Satouchi, M, Negoro, S, Funada, Y, Urata, Y, Shimada, T, Yoshimura, S, Kotani, Y, Sakuma, T, Watanabe, H, Adachi, S, Takada, Y, Yatabe, Y, Mitsudomi, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360147/
https://www.ncbi.nlm.nih.gov/pubmed/17387341
http://dx.doi.org/10.1038/sj.bjc.6603710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360147/
https://www.ncbi.nlm.nih.gov/pubmed/17387341
http://dx.doi.org/10.1038/sj.bjc.6603710

Ejemplares similares